Compare BioNTech SE - ADR (BNTX) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? BioNTech SE - ADR trades at $93.31 (market cap $23.31B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.68. Which is the better fit depends on your goals.
| BNTX | VTIP | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | — |
52-Week High | $119.34 | $50.75 |
52-Week Low | $83.89 | $49.39 |
Enterprise Value | $6.60B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BioNTech (BNTX) trades at $93.27, up 0.51% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported Q2 2026 revenue of $106 million, missing expectations, and lowered its full-year sales outlook due to weak COVID-19 vaccine demand. Despite negative net income margins and cash outflows, BNTX maintains a strong cash position of $16.78 billion and is advancing its oncology pipeline with 14 pivotal clinical trials.
The outlook is mixed: analyst consensus is strongly bullish with a $121 price target, but declining COVID revenue and ongoing losses pose significant risks. Investment opportunity hinges on successful pipeline development, while near-term headwinds from vaccine demand softness and leadership transition require careful monitoring.
VTIP trades at $49.695 with minimal daily movement (+0.03%). Technical indicators show a neutral overall signal with bearish moving averages, while RSI readings suggest balanced momentum. The ETF focuses on short-term inflation-protected securities, offering protection against rising costs with current inflation projections around 3.8%. Recent institutional buying includes 55 North Private Wealth increasing holdings by 12.2%.
VTIP provides inflation hedging with expected returns slightly above comparable treasuries. The Fed's stance against rate cuts in 2026 supports short-term TIPS, though inflation volatility remains a key risk. Analyst sentiment is cautiously positive given the inflation environment, making VTIP a strategic defensive holding for income-focused investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
